- In March 2024, Hindustan Syringes and Medical Devices (HMD) launched Dispojekt single-use syringes with safety needles, aimed at reducing Needle Stick Injuries (NSIs) among healthcare workers. These syringes are expected to lower infection control costs, disposal expenses, and training needs, providing long-term financial benefits to the healthcare sector. With domestically manufactured, advanced technology, HMD is positioning India to compete globally in the sharp injury prevention syringe market, strengthening its market presence both locally and internationally
- In November 2023, Terumo India, the Indian arm of global medical technology leader Terumo Corporation, announced the launch of its Insulin Syringe, a sterile delivery device designed for patients requiring regular insulin injections. This new product aims to enhance patient comfort and improve therapy compliance, setting a higher standard for diabetes care
- In September 2022, Terumo India, the Indian arm of global medical technology leader Terumo Corporation, launched the FineGlide Sterile Pen Needle for patients requiring regular insulin injections or other self-medication. Compatible with most commonly available pen devices in India, FineGlide is designed to enhance patient comfort, ultimately improving drug compliance. This launch aims to raise the standard of care for individuals managing chronic conditions in India
- In May 2022, Roche Diabetes Care India (RDC India) introduced Accu-Fine, a line of high-quality pen needles designed to enhance the insulin delivery experience for individuals with diabetes. This new offering from Roche Diabetes Care, known for its Accu-Chek brand, is aimed at improving the ease of insulin delivery, ultimately supporting better diabetes management for patients
